Quince Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for QNCX, updated each market day.
QNCX AI Sentiment
AI predicts Quince Therapeutics, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Quince Therapeutics, Inc. Common Stock
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Sector
Exchange
Market Cap
$22,169,081
Cap Tier
Employees
38
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
May 9, 2019
Website
QNCX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
QNCX Volatility
Quince Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
